Navigation Links
Pregnant women can receive breast cancer chemotherapy without endangering health of their babies
Date:3/25/2010

Barcelona, Spain: Women who discover they have breast cancer while they are pregnant can be treated with chemotherapy without endangering the health of their unborn baby, according to research to be presented at the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Friday).

Dr Sibylle Loibl, Assistant Professor in Obstetrics and Gynaecology at the University of Frankfurt, Germany, and a member of the German Breast Group, will tell the conference that pregnant breast cancer patients can be treated as close as possible to standard recommendations because chemotherapy delivered while babies were in the womb did not appear to cause the babies significant problems at or after birth.

"Until now, the evidence upon which we based our decisions about how to treat pregnant women with breast cancer has been largely limited to case studies and retrospective investigations. For this reason doctors have tended to be cautious in their approach to treatment because of fears about the effect it might have on the foetus, even though it meant that women did not necessarily receive the best treatment for their cancer," said Dr Loibl. "Therefore, the German Breast Group set up a registry to collect data both retrospectively and prospectively from patients who have been diagnosed with breast cancer during pregnancy. It is the only international registry to focus on the outcomes of both the mother and the baby."

The researchers entered details of 235 patients prospectively (119) and retrospectively (116) to the registry between April 2003 and October 2009. The ages of the women ranged between 23 and 46 with an average (median) age of 33. Breast cancer was diagnosed, on average, at 23 weeks into the pregnancy. Not all the data are complete yet, but out of 151 women, 91 received an average of two cycles of chemotherapy while they were pregnant.

The average gestational age of the babies at the time of delivery was 36 weeks, ranging between 28 and 42 weeks. Babies that were exposed to chemotherapy during pregnancy were born slightly lighter than babies who were not: an average of 2636mg, compared to 2791mg.

Of the 91 babies exposed to chemotherapy, three were born bald (alopecia), one was small for gestational age, one had trisomia 18 (a chromosomal disorder) and died one week after birth, one had necrotic enterocolitis (a severe bacterial infection of the intestine) and died three weeks after birth, one developed sepsis (blood infection), one developed neutropenia (low white blood cell count) and two had anaemia. Of the 60 babies who were not exposed to chemotherapy, one had temporary apnoea (breathing interruption), one had an increase in C reactive protein (a protein that appears in response to inflammation or infection) and one had gastroenteritis.

Dr Loibl said: "Most of the problems described in the babies exposed to chemotherapy were not related to the treatment but were most probably due to other circumstances (for instance, necrotic enterocolitis due to preterm delivery or trisomia 18). Normally, in nature, there is a risk of malformations of between one and two percent, and other problems such as infection can happen. The foetal outcomes of these babies that received chemotherapy were not significantly different from those who did not.

"Therefore, this study suggests that pregnant breast cancer patients can be treated as close as possible to standard recommendations and receive chemotherapy, if it is indicated, while they are pregnant. Ideally, this should take place in the care of specialised, multidisciplinary teams. We would like to generate more robust data to confirm this and so the registry is continuing and we are updating and completing the data."

In addition to the data on outcomes for mothers and babies, Dr Loibl and her colleagues are also collecting tumour specimens and placenta material from the women who are being followed prospectively, and these are sent to the German Breast Group's biomaterial bank. The researchers hope that this will give them important information in the future about the effects of pregnancy and chemotherapy on outcomes for mothers and babies.


'/>"/>

Contact: Emma Mason
wordmason@mac.com
ECCO-the European CanCer Organisation
Source:Eurekalert

Related medicine news :

1. New Research Shows Genes of Pregnant Women and Their Fetuses Can Increase the Risk of Preterm Labor
2. Genes of pregnant women and their fetuses can increase the risk of preterm labor
3. A pregnant woman does not look like an olive
4. Pregnant women who are overweight put their infants at risk
5. CARE: Tens of Thousands of Pregnant Women at Risk in Haiti
6. Appeal Launched for Emergency Assistance to Thousands of Pregnant Women at High Risk in Haiti
7. Almost two-thirds of pregnant women believe they are regularly exposed to physical risk at work
8. Airbags Appear Safe for Pregnant Women
9. Swine Flu Hits Pregnant Women, Kids Hardest
10. Precautions Allow for Smooth Travel While Pregnant
11. Drinking Milk While Pregnant May Lower Kids MS Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... June 23, 2016 , , ... July 7, 2016 , , , , LOCATION: , , ... , , , EXPERT PANELISTS:  , , , Frost & ... Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, ... The global pharmaceutical industry is witnessing an exceptional era. Several new ...
(Date:6/23/2016)... June 23, 2016 Revolutionary technology ... Oticon , industry leaders in advanced audiology and ... Oticon Opn ™, the world,s first internet connected ... for IoT devices.      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ... a number of ,world firsts,: , TwinLink™ ...
Breaking Medicine Technology: